Aaron Falchook, MD

Most metastatic cancer patients are still receiving aggressive methods of treatment near the end of life, and palliative/supportive measures are significantly underutilized.

To date, there is still no strong evidence that induction chemotherapy improves outcomes for locally advanced head and neck cancer.

As physicians, we strive to do no harm, and there is a narrow therapeutic window when treating elderly patients with cancer.

Advocacy is about making sure that our lawmakers enact the best healthcare policies for our patients. Just as we have a duty to our patients in the clinic, we also have a duty to advocate for laws that benefit patients’ health.

A 58-year-old man treated with chemoradiotherapy for squamous cell carcinoma of the tonsil presents at follow-up with pain in the back of his mouth. What is the most likely diagnosis?

A 53-year-old man treated for squamous cell carcinoma of the anus presents 4 weeks post-treatment with a 2-cm anal mass. What is the most appropriate next step in his management?

Imaging on a 60-year-old man demonstrates multiple bony lesions in the spine that could indicate metastatic liver cancer. What is the best diagnostic tool to confirm the diagnosis?

At this year’s ASCO GU Cancers Symposium, several high-impact and potentially practice-changing abstracts were presented during the prostate cancer session.

We are in the midst of a radical shift in the way modern medicine is practiced, and there are many challenges facing physicians today. So, why did I become one?

After receiving a PSA screening exam, a 65-year-old man is diagnosed with clinical stage T1c prostate cancer. What imaging study is most appropriate to complete his workup?

The benefit of hypofractionated radiotherapy for women receiving breast-conserving therapy for early-stage breast cancer is becoming more apparent.

While observation may be appropriate for select cases where prognosis is poor, rates of non-treatment are unacceptably high in muscle-invasive bladder cancer.

In the field of oncology, we are fortunate to possess a vast and ever-expanding trove of knowledge, and we now have a sufficient foundation of knowledge in many cancers to afford ourselves the luxury of striving to seek wisdom as well.

With cancer care costs rising rapidly there is increased pressure to search for value in how we care for our patients.

The University of North Carolina has multiple posters accepted to the Gynecologic Oncology General Poster Session at this year’s ASCO meeting. Let’s take a virtual walk through several of these abstracts.

It’s Saturday morning, and ASCO is fully underway. I started the morning at the immense poster exhibit hall. Although it is easy to feel intimidated by the size of the room and number of posters, I find that walking the poster hall can actually be one of the most personal and intimate ways to experience the ASCO meeting.